BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $367K of BioMarin Pharmaceutical Inc.
Sold$367,120
$91.78Price
4,000Shares
−1%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Wed, Feb 27. Filed Thu, Feb 28, 8:24 PM ET, after the close. Not investment advice.